Category: Investor updates

The document “Notification of Issue, Conversion of Payment up of Equity +Securities” was lodged with ASX on 14 December 2020. Please click to review the

Imagion Biosystems announces that Ms Jovanka Naumoska has resigned from her position as Company Secretary of Imagion Biosystems, effective today, 8 December 2020. Ms Naumoska

The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 26 November, 2020. Please click to review the

Imagion Biosystems is pleased to announce the issue of the shares under the Placement (Placement) as announced to the market on 23 November 2020. The

The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 25 November 2020. Please click to review the

Imagion Biosystems announces that it has received a total of $644,100.00 for the exercise of Options. Please click to review the full announcement at ASX.

Imagion Biosystems Limited announced a proposed issue of securities on 22 November 2020. Please click to review the full announcement at ASX.  

Imagion Biosystems is pleased to announce it has raised $6M via a placement, at 8.5c per share. The placement, led by Evolution Capital Advisors, was

The securities of Imagion Biosystems Limited (‘IBX’) will be placed in trading halt at the request of IBX, pending it releasing an announcement. Unless ASX

Imagion Biosystems advises that in accordance with Listing Rule 4.7C.3, and as noted in the Item 6 of the Appendix 4C Cashflow Statement lodged by